Berberine, an alkaloid with antitumor properties, inhibits the Warburg effect in ovarian cancer cells by enhancing TET3-mediated demethylation via the TET3/miR-145/HK2 signaling pathway (88). This evidence concerns the gene TET3 and ovarian carcinoma.